Literature DB >> 15931379

Finding schizophrenia genes.

George Kirov1, Michael C O'Donovan, Michael J Owen.   

Abstract

Genetic epidemiological studies suggest that individual variation in susceptibility to schizophrenia is largely genetic, reflecting alleles of moderate to small effect in multiple genes. Molecular genetic studies have identified a number of potential regions of linkage and 2 associated chromosomal abnormalities, and accumulating evidence favors several positional candidate genes. These findings are grounds for optimism that insight into genetic factors associated with schizophrenia will help further our understanding of this disease and contribute to the development of new ways to treat it.

Entities:  

Mesh:

Year:  2005        PMID: 15931379      PMCID: PMC1137005          DOI: 10.1172/JCI24759

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  117 in total

1.  A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6.

Authors:  S G Schwab; J Hallmayer; M Albus; B Lerer; G N Eckstein; M Borrmann; R H Segman; C Hanses; J Freymann; A Yakir; M Trixler; P Falkai; M Rietschel; W Maier; D B Wildenauer
Journal:  Mol Psychiatry       Date:  2000-11       Impact factor: 15.992

Review 2.  Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics.

Authors:  A G Cardno; I I Gottesman
Journal:  Am J Med Genet       Date:  2000

3.  Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23.

Authors:  H M Gurling; G Kalsi; J Brynjolfson; T Sigmundsson; R Sherrington; B S Mankoo; T Read; P Murphy; E Blaveri; A McQuillin; H Petursson; D Curtis
Journal:  Am J Hum Genet       Date:  2001-03       Impact factor: 11.025

4.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

Authors:  A Abi-Dargham; J Rodenhiser; D Printz; Y Zea-Ponce; R Gil; L S Kegeles; R Weiss; T B Cooper; J J Mann; R L Van Heertum; J M Gorman; M Laruelle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22.

Authors:  L M Brzustowicz; K A Hodgkinson; E W Chow; W G Honer; A S Bassett
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

6.  Disruption of two novel genes by a translocation co-segregating with schizophrenia.

Authors:  J K Millar; J C Wilson-Annan; S Anderson; S Christie; M S Taylor; C A Semple; R S Devon; D M St Clair; W J Muir; D H Blackwood; D J Porteous
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

7.  Linkage of familial schizophrenia to chromosome 13q32.

Authors:  L M Brzustowicz; W G Honer; E W Chow; D Little; J Hogan; K Hodgkinson; A S Bassett
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

8.  Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis.

Authors:  T H Shaikh; H Kurahashi; S C Saitta; A M O'Hare; P Hu; B A Roe; D A Driscoll; D M McDonald-McGinn; E H Zackai; M L Budarf; B S Emanuel
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

9.  Finnish adoptive family study: sample selection and adoptee DSM-III-R diagnoses.

Authors:  P Tienari; L C Wynne; J Moring; K Läksy; P Nieminen; A Sorri; I Lahti; K E Wahlberg; M Naarala; K Kurki-Suonio; O Saarento; P Koistinen; T Tarvainen; H Hakko; J Miettunen
Journal:  Acta Psychiatr Scand       Date:  2000-06       Impact factor: 6.392

Review 10.  Molecular determinants of metabotropic glutamate receptor signaling.

Authors:  A De Blasi; P J Conn; J Pin; F Nicoletti
Journal:  Trends Pharmacol Sci       Date:  2001-03       Impact factor: 14.819

View more
  40 in total

1.  Association study of H2AFZ with schizophrenia in a Japanese case-control sample.

Authors:  Daisuke Jitoku; Naoki Yamamoto; Yoshimi Iwayama; Tomoko Toyota; Momo Miyagi; Takeshi Enokida; Yuri Tasaka; Masakazu Umino; Asami Umino; Akihito Uezato; Yasuhide Iwata; Katsuaki Suzuki; Mitsuru Kikuchi; Tasuku Hashimoto; Nobuhisa Kanahara; Akeo Kurumaji; Takeo Yoshikawa; Toru Nishikawa
Journal:  J Neural Transm (Vienna)       Date:  2014-11-13       Impact factor: 3.575

Review 2.  The peroxisome: an update on mysteries.

Authors:  Markus Islinger; Sandra Grille; H Dariush Fahimi; Michael Schrader
Journal:  Histochem Cell Biol       Date:  2012-03-14       Impact factor: 4.304

3.  Genetic variation in G72 correlates with brain activation in the right middle temporal gyrus in a verbal fluency task in healthy individuals.

Authors:  Axel Krug; Valentin Markov; Sören Krach; Andreas Jansen; Klaus Zerres; Thomas Eggermann; Tony Stöcker; N Jon Shah; Markus M Nöthen; Alexander Georgi; Jana Strohmaier; Marcella Rietschel; Tilo Kircher
Journal:  Hum Brain Mapp       Date:  2011-01       Impact factor: 5.038

Review 4.  [Cognitive disorders in schizophrenic patients].

Authors:  H-P Volz; F Reischies; M Riedel
Journal:  Nervenarzt       Date:  2010-01       Impact factor: 1.214

Review 5.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Authors:  John E Lisman; Joseph T Coyle; Robert W Green; Daniel C Javitt; Francine M Benes; Stephan Heckers; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

Review 6.  Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms.

Authors:  Joseph T Coyle
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 7.  Glutamate and schizophrenia: beyond the dopamine hypothesis.

Authors:  Joseph T Coyle
Journal:  Cell Mol Neurobiol       Date:  2006-06-14       Impact factor: 5.046

8.  Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia.

Authors:  Yang Liu; Gang Chen; Nadine Norton; Wenmin Liu; Haining Zhu; Peng Zhou; Meng Luan; Shulin Yang; Xing Chen; Liam Carroll; Nigel M Williams; Michael C O'Donovan; George Kirov; Michael J Owen
Journal:  J Biomed Biotechnol       Date:  2009-10-27

9.  Shared and distinct alterations of white matter tracts in remitted and nonremitted patients with schizophrenia.

Authors:  Jing-Ying Huang; Chih-Min Liu; Tzung-Jeng Hwang; Yu-Jen Chen; Yung-Chin Hsu; Hai-Gwo Hwu; Yi-Tin Lin; Ming-Hsien Hsieh; Chen-Chung Liu; Yi-Ling Chien; Wen-Yih Isaac Tseng
Journal:  Hum Brain Mapp       Date:  2018-01-28       Impact factor: 5.038

10.  Genetic variation in the schizophrenia-risk gene neuregulin 1 correlates with brain activation and impaired speech production in a verbal fluency task in healthy individuals.

Authors:  Tilo Kircher; Axel Krug; Valentin Markov; Carin Whitney; Sören Krach; Klaus Zerres; Thomas Eggermann; Tony Stöcker; Nadim Jon Shah; Jens Treutlein; Markus M Nöthen; Tim Becker; Marcella Rietschel
Journal:  Hum Brain Mapp       Date:  2009-10       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.